baber/WOPTO huggingface dataset:
Patent IL-123168-A0 (IL)
Title: Phosphorus-containing iron powders and their preparation
IPC: B22F1/00
Filed: 1998-02-03
Abstract: A process for producing phosphorus-containing iron powder involves heating a mixture of finely divided carbonyl iron and elemental phosphorus and pulverising the product. Preferably, a mixture of 70-99 wt.% finely divided carbonyl iron powder and 1-30 wt.% red phosphorus is heated at above 300 degrees C in an inert gas atmosphere. Also claimed is a phosphorus-containing iron powder of less than 10 mu  mean particle diameter, containing 0.1-80 wt.% P, less than 1 wt.% C, less than 1 wt.% N, less than 0.5 wt.% H and less than 0.1 wt.% total of other impurity elements except oxygen.
Patent IL-123514-A0 (IL)
Title: Antagonists of the oncogenic activity of the protein MDM2 and use thereof in the treatment of cancers
IPC: A61K45/00
Filed: 1996-09-02
Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
Patent IL-124925-A0 (IL)
Title: Quinazoline derivatives
IPC: C07D239/94
Filed: 1996-12-13
Abstract: The invention relates to quinazoline derivatives of the formula: [wherein: Y1 represents -O-, -S-, -CH2-, -SO-, -SO2-, -NR5CO-, -CONR6-, -SO2NR7-, -NR8SO2- or -NR9- (wherein R5, R6, R7, R8 and R9 each independently represents hydrogen, alkyl or alkoxyalkyl); R1 represents hydrogen, hydroxy, halogeno, nitro, trifluoromethyl, cyano, alkyl, alkoxy, alkylthio, amino or alkylamino. R2 represents hydrogen, hydroxy, halogeno, alkyl, alkoxy, trifluoromethyl, cyano, amino or nitro; m is an integer from 1 to 5; R3 represents hydroxy, halogeno, alky, alkoxy, alkanoyloxy, trifluoromethyl, cyano, amino or nitro; R4 represents a group which is or which contains an optionally substituted pyridone, phenyl or aromatic heterocyclic group] and salts thereof; processes for their preparation and pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent IL-138425-A0 (IL)
Title: Solid-state magnetic resonance imaging
IPC: G01R33/54
Filed: 1999-03-12
Abstract: Principles of magnetic resonance are employed to generate data, such as image intensity data, reflecting the spatial distribution of one or more isotopes carried in a solid-state specimen such as bone. The spatial distribution data can be employed, e.g., to calculate bone mineral density and/or degree of mineralization.
Patent IL-139457-A0 (IL)
Title: Compounds for the treatment of female sexual dysfunction
IPC: A61K31/554
Filed: 2000-11-02
Abstract: A pharmaceutical composition (C1) comprising an inhibitor of neutral endopeptidase (NEP) (a1) with carrier, diluent or excipient optionally with additional pharmaceutical agent (preferably NEP, phosphodiesterase (PDE) and/or neuropeptide Y (NPY) inhibitor), is new. Independent claims are included for: (1) performing an assay method for identifying an agent that can be used to treat female sexual dysfunction (FSD) involving determining whether an agent can directly or indirectly potentiate cyclic adenosine-3',5'-monophosphate (cAMP) where a potentiation of cAMP in the presence of the agent is indicative that the agent can be useful in the treatment of FSD where the agent is (a1), identifying at least one agent that can directly or indirectly potentiate cAMP, preparing the identified agents, mixing the identified agent with carrier, diluent or excipient to form (C1), and packaging (C1); (2) an assay process for identifying an agent that can treat FSD involving administering an agent to an animal model, measuring any potentiation of cAMP and/or increase in blood flow in the genitalia of the animal, where the agent is (a1) and the animal model comprises at least one of an anesthetized female animal including device to measure changes in genital blood flow of the animal following stimulation of the pelvic nerve where the agent potentiates cAMP in the sexual genitalia following optionally oral administration; (3) a diagnostic method involving isolating a sample from a female, determining whether the sample contains an entity (e1) to cause FSD, whether the entity has a direct or indirect effect on the level of activity of cAMP in the sexual genitalia of the female and whether the entity can be modulated to achieve a beneficial effect by using (a1); and (4) a diagnostic kit comprising device for detecting (e1) in an isolated female sample, and (a1). ACTIVITY : Endocrine-Gen. MECHANISM OF ACTION : Neutral endopeptidase (NEP) inhibitor; Mediator of female genital vasorelaxation. Test details are described but no results for the specific compounds given.
Patent IL-139653-A0 (IL)
Title: Signal noise reduction by spectral subtraction using linear convolution and causal filtering
IPC: G10L21/0208
Filed: 1999-05-27
Abstract: Methods and apparatus for providing speech enhancement in noise reduction systems include spectral subtraction algorithms using linear convolution, causal filtering and/or spectrum dependent exponential averaging of the spectral subtraction gain function. According to exemplary embodiments, low order spectrum estimates are developed which have less frequency resolution and reduced variance as compared to spectrum estimates in conventional spectral subtraction systems. The low order spectra are used to form a gain function having a desired low variance which in turn reduces musical tones in the spectral subtraction output signal. Advantageously, the gain function can be further smoothed across blocks using input spectrum dependent exponential averaging. Additionally, the low order of the gain function permits a phase to be added during interpolation so that the spectral subtraction gain filter is causal and prevents discontinuities between blocks.
Patent IL-144493-A0 (IL)
Title: Improved process for maunfacture of polyvinyl chloride
IPC: C08F2/18
Filed: 2001-07-23
Abstract: In the process according to the invention for the aqueous suspension polymerization of vinyl chloride, alone or as a mixture with another vinyl monomer, the polymerization initiator comprises at least one compound chosen from dialkyl peroxydicarbonates, peroxy-tert-alkanoates and diacyl peroxides and use is made, as agent for halting the polymerization, of a mono- or disubstituted hydroxylamine. The resins thus obtained exhibit improved color and heat stability.
Patent IL-149885-A0 (IL)
Title: A non-human multicellular organism and methods for controlling the same
IPC: A01K67/033
Filed: 2000-11-29
Abstract: The invention relates to a non-human multicellular organism carrying a dominant lethal genetic system, the lethal effect of which is conditional, wherein the lethal effect of the lethal system occurs in the natural environment of the organism.
Patent IL-152213-A0 (IL)
Title: Spatial and spectral wavefront analysis and measurement
IPC: G11B7/005
Filed: 2001-04-11
Abstract: A method and apparatus for wavefront analysis including obtaining a plurality of differently phase changed transformed wavefronts corresponding to a wavefront being analyzed which has an amplitude and a phase, obtaining a plurality of intensity maps of the plurality of phase changed transformed wavefronts and employing the plurality of intensity maps to obtain an output indicating the amplitude and phase of the wavefront being analyzed.
Patent IL-156952-A0 (IL)
Title: A foldable pushchair for babies
IPC: B62B7/04
Filed: 2003-07-16
Abstract: The foldable pushchair has a pair of rear wheels and a single front wheel. It has a footrest (5) with a bolted connection to the lower part of the converging front frame tubes (3,4). The front wheel assembly (1) is mounted to the footrest which can be locked in the folded and deployed positions. The front frame tubes have a plate (26) on which the foot plate lock is mounted.
Patent IL-158138-A0 (IL)
Title: Printhead assembly having flexible printed circuit board and busbars
IPC: B41J2/14
Filed: 2002-03-27
Abstract: A modular printhead is disclosed which includes an elongate channel and a plurality of printhead modules. The printhead modules are received in the elongate channel. Each printhead module has a carrier, an elongate ink delivery member mounted in the carrier and a printhead. The elongate ink delivery member defines longitudinal conduits, each conduit carrying a respective ink. The elongate ink delivery member further defines sets of apertures, each set of apertures including apertures which are each in register with a corresponding conduit. The printhead includes inkjet nozzles, each inkjet nozzle being in fluid communication with a respective conduit.
Patent IL-174156-A0 (IL)
Title: Method for detecting procoagulant phospholipid
IPC: H03L7/22
Filed: 2006-03-07
Abstract: The present invention relates to a method for determining the amount of procoagulant phospholipid in a sample, said method comprising steps (i) to (iii) performed in the following order: (i) forming an admixture of the sample and a substrate plasma which has been rendered free or substantially free of procoagulant phospholipid sufficient to at least reduce the capacity of the substrate plasma to coagulate, wherein said substrate plasma has been rendered free or substantially free of procoagulant phospholipid by treatment with a phospholipase; (ii) contacting the admixture with a reagent for activating coagulation of plasma in conditions were procoagulant phospholipids is the rate limiting component of the mixture; and (iii) determining the clotting time if the admixture.
Patent IL-190907-A0 (IL)
Title: Methods and apparatus for a navigation system with reduced susceptibility to interference and jamming
IPC: G01S19/21
Filed: 2008-04-16
Abstract: A navigation system provides a significant level of protection against all forms of interference or jamming to GPS in a cost-effective way. The system employs a network of ground reference stations and Low Earth Orbiting (LEO) satellites in conjunction with GPS. A common-view ranging geometry to a GPS satellite is established that links a reference station and a user. A second common-view geometry to a LEO satellite between the same reference station and user pair is also established. The ground stations synthesize real-time aiding signals by making carrier phase measurements of GPS the LEO satellite signals. This aiding information is transmitted via the LEO satellites to the user receiver at high power to penetrate ambient jamming. The user receiver locks onto the carrier phase of the LEO satellite, demodulates the aiding information, then applies the carrier phase measurements and the aiding information to enable extended coherent measurements of the GPS signals. The system thereby recovers the GPS signals that would otherwise be lost to the jamming.
Patent IL-192355-A0 (IL)
Title: Method and apparatus for power control in a wireless communication system
IPC: H04B7/005
Filed: 2008-06-19
Abstract: Method and Apparatus for performing power control on the power control commands transmitted on a forward link in a wireless communication system. The power level of the power control bits on the forward link are adjusted in response to power commands received on the reverse link. The mobile station measures the power level of the adjusted power control bits to measure the quality of the forward link.
Patent IL-200130-A0 (IL)
Title: Methods for detecting inflammatory bowel disease
Filed: 2009-07-28
Abstract: The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.
Patent RO-125478-A0 (RO)
Title: Succession indicator
Inventor: CUJBĂ TIBERIU OCTAVIAN
IPC: G01R29/18
Filed: 2009-04-21
Abstract: The invention relates to an indicator of the phase succession for a three-phase voltage source. According to the invention, the indicator consists of a magnetic system (1) with three columns having an "E" shape, on the said columns there being placed some y-connected coils (2a, 2b and 2c), and at the free side of the extreme columns there being fastened a yoke (3), in the middle of which there is supported, on two bearings for conical points, the axle of a cylindrical rotor (4) with the aspect of a helical multiple-thread screw, whose motion is viewed through a magnifying glass (5) mounted inside an electro-insulating casing.
Patent RO-125569-A0 (RO)
Title: Process for pointing out self-similarity of internet traffic
Inventor: ULRICH ROLAND ANDREI
IPC: H04L12/28
Filed: 2009-05-12
Abstract: The invention relates to a process for pointing out self-similarity of traffic packages in Internet. According to the invention, the process consists of a series of steps which are taken sequentially, consisting in: making the free scale topology of the network centers, followed by making the topology of the traffic sources, afterwards there is executed a traffic simulation, the data captured after the simulation being aggregated in a time series, then there being estimated the self-similarity parameter Hurst, after which there may be determined if the traffic is of self-similar nature or not, information which is, finally, stored in a database.
Patent RO-133831-A0 (RO)
Title: Process for manufacturing motor-vehicle electrical wiring and devices associated therewith
Inventor: CREŢ VASILE
IPC: B65H59/00
Filed: 2019-06-13
Abstract: The invention relates to a process of simultaneous manufacturing of motor-vehicle wiring. According to the invention, the process consists of a staggered fixation of the cable ends into some channels (I, II, III, ...) or deviated by 90° on the middle of some cross sectors (1, 2, 3, ...) in some blocking devices (F), on a working surface (S) of a device and then, by moving the mentioned surface in relation to the cable supply points, drawing thereof into the respective channels through the arms of some forks (FR), the cables being supplied through some guiding rings (I) on some ring bars (BI) positioned in front of the cable laying channels.
Patent AP-2000001969-A0 (AP)
Title: A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease.
Inventor: VERSCHOOR JAN ADRIANUS
IPC: A61K39/04
Filed: 1998-03-03
Abstract: A composition comprising a purified lipid cell-wall component or analog or derivative thereof and a suitable pharmaceutical carier, medium, excipient or adjuvant is described. The composition is useful in prophylactic and therapeutic methods of treating a microbial infection in a subject, typically a mycobacterial infection such as tuberculosis, and immune disorders, inflammatory conditions and allergies in a subject, typically autoimmune diseases. It is also useful in diagnostic methods. The purified lipid cell-wall component is typically a purified mycolic acid or a mixture of purified mycolic acids from a bacterium which produces mycolic acids. The bacterium is from mycobacterium, corynebacterium, nocardia or rhodococcus.
Patent AP-2000001985-A0 (AP)
Title: Novel formulation containing paroxetine.
Inventor: ELDER DAVID PHILIP
IPC: A61K9/48
Filed: 1999-05-13
Abstract: Paroxetine hydrochloride, in a form other than the hemihydrate, which is formulated into capsules under conditions such there is no detectable conversion to hemihydrate during the manufacturing process
Patent AU-2002951658-A0 (AU)
Title: Explosively actuated tools
IPC: F41A19/40
Filed: 2002-09-25
Abstract: The tool has a firing mechanism with cocking rod (4) and sear for entraining a firing pin with the pin released on cocking by rotation of the sear. The rod and the sear form a structure subject to an axial and rotational bias by a spring anchored to the rod. A mounting is rotated to apply torsional loading to the spring and locked to rod housing (2) in an angular orientation in which the loading is maintained in the spring. An independent claim is also included for a method of assembling an explosively actuated tool for driving a fastener into a substrate.
Patent CU-21917-A1 (CU)
Title: Esclusa hermetica para cubiertas protectoras de los reactores nucleares
Inventor: ZIMENS YAKOV YAKOVLEVICH
IPC: E04H9/00
Filed: 1986-05-30
Abstract: La esclusa hermética consta de un cuerpo (1) con plataforma (2) y partes herméticas (3,4) provistas de un mecanismo de obturación que cinemáticamente, a través de un mecanismo (15,16) de distribución del movimiento va unido al sistema de mando de la esclusa y a válvulas de nivelación (17). La platafaroma (2) está hecha en forma de una parte inmóvil y una plataforma móvil (5) colocada con ayuda de un sistema de palancas con resortes (7) en el marco de apoyo (6) y provisto de un mecanismo de suspensión hecho en forma de varilla (10) con tope (11), que va unida articuladamente a una de las palancas con resorte (7) e interacciona con la hoja de la puerta (3). La plataforma móvil (5) está provista de transmisores (18) de posiciones, vinculados al sistema de mando de la esclusa.
Patent MC-2265-A1 (MC)
Inventor: SCHALLY ANDREW V
IPC: C07K14/575
Filed: 1991-04-08
Abstract: The present invention deals with LHRH analogs which contain cytotoxic moieties, have influence on the release of gonadotropins from the pituitary in mammals (possess high agonistic or antagonistic activity) and have antineoplastic effect. The compounds of this invention are represented by Formula I: X-R<1>-R<2>-R<3>-Ser-R<5>-R<6>(Q)-Leu-Arg-Pro-R<1><0>-NH2, wherein R<1> is pGlu or D-Nal(2), R<2> is His or D-Phe(4Cl), R<3> is Trp, D-Trp or D-Pal(3), R<5> is Tyr or Arg, R<6> is D-Lys or D-Orn, R<1><0> is Gly or D-Ala, X is hydrogen or a lower alkanoyl group of 2-5 carbon atoms, Q is a cytotoxic moiety having the formula -Q<4> or -A(Q<3>) or B(Q<1>)2 or -B(AQ<2>)2, wherein A is -NH-(CH2)n-CO- or -OC-(CH2)n-CO- where n is 2-6, B is -NH-CH2-(CH2)m-CH(NH)-(CH2)n-CO- where m is 0 or 1, n is 0 or 1, the -CO moiety of A- and of B- being bonded to an amino group on R<6>, and in the group B(AQ<2>)2, the -CO moiety of A-being bonded to an amino group on B, Q<1> is D or L-Mel, cyclopropanealkanoyl, aziridine-2-carbonyl, epoxyalkyl or 1,4-naphthoquinone-5-oxycarbonyl-ethyl, Q<2> is Q<<1>,> anthraquinonylalkoxy or doxorubicinyl, Q<3> is Q<2>, mitomicinyl, esperamycinyl or methotrexoyl, Q<4> is Q<1> or methotrexoyl and pharmaceutically acceptable salts thereof and methods of use pertaining these compounds.
Patent ZM-2892-A1 (ZM)
Title: Imidazo (1,2-a) (pyrrolo thieno or furano) (3,2-d) azepine derivatives compositions and method of use
Inventor: JANSSENS FRANS EDUARD
IPC: C07D519/00
Filed: 1992-06-12
Abstract: The present invention is concerned with novel imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepines of formula <CHEM> the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond;     R<1>   represents hydrogen, C1-4alkyl, halo, ethenyl substituted with hydroxycarbanyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl, hydroxycarbonyl or hydroxycarbonylC1-4alkyl; R<2>   represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R<3>   represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; L   represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonylC1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; L represents a radical of formula -Alk-Y-Het<1> (a-1), -Alk-NH-CO-Het<2> (a-2) or -Alk-Het<3> (a-3); which are useful antiallergic compounds. Compositions comprising said compounds, methods of using, and processes for preparing the same.
Patent IE-910214-A1 (IE)
Title: Microbicidal compositions
IPC: C07D333/18
Filed: 1991-01-22
Abstract: Novel 2-arylacrylonitrile derivatives of the formula I  which exist in the form of mixtures (E,Z) or in the form of pure E and Z isomers, in which R1 is C5-C7-cycloalkyl or C1-C6-alkyl which is unsubstituted or substituted by halogen or C1-C4-alkoxy, or is the radicals T, U, U', V or V'  in which m is the numbers 0-4, n is the numbers 0-2, R3 together with R2 or with R4 is the radical  where R7 is hydrogen, fluorine or C1-C4-alkyl, or in which R2-R6 independently of one another are hydrogen, halogen, carboxyl, C1-C4-alkoxycarbonyl, nitro, cyano, or the radicals C1-C4-alkyl, phenyl, C1-C4-alkoxy or C1-C4-alkylthio, each of which is unsubstituted or substituted by halogen, and R8 is halogen or C1-C4-alkyl, A is the radical  in which R10 together with R9 or R11 is the radical  or in which R9-R13 independently of one another are hydrogen, halogen, carboxyl, C1-C4-alkoxycarbonyl, nitro, cyano, the radicals  where R14 is hydrogen, halogen or C1-C4-alkyl, or R9-R13 are the radicals C1-C4-alkyl, C1-C4-alkoxy or C1-C4-alkylthio, unsubstituted or substituted by halogen, or the radicals U, U', V and V', and X is -OSO2-, -SO- or -SO2-, where, if X is the radical -OSO2-, R14 is hydrogen or chlorine and R9, R10, R12 and R13 are hydrogen and T is not the p-tolyl radical, and if X is the radical -SO2-, R1 is not the trifluoromethyl radical. The active substances of the formula I are used for controlling harmful microorganisms, in particular phytopathogenic fungi. They can be employed as agents together with suitable formulation auxiliaries.
Patent MA-23314-A1 (MA)
Inventor: KENDRICK JOU HUGHES
IPC: A61K8/00
Filed: 1995-08-26
Abstract: Provided is a topical personal care composition, having improved drying time, said composition comprising: (a) a polysiloxane-grafted adhesive polymer; (b) a volatile, water insoluble solvent for said polysiloxane-grafted polymer; (c) a nonvolatile drying aid for said polysiloxane-grafted polymer which is soluble in said volatile solvent (b) at 45 DEG  C. and is water insoluble at 25 DEG  C., and is selected from the group consisting of silicone fluids and waxes having from 1 to about 100 siloxy units, silanes, and silicone resins and mixtures thereof; wherein the weight ratio of said polysiloxane-grafted polymer (a) to said drying aid (c) is about 100:1 or less.
Patent MA-44034-A1 (MA)
Title: Procédé de raccordement de deux éléments unitaires d'une conduite sous-marine de transport de fluides soumise a la fatigue
Inventor: YOUSFI RACHID
IPC: F16L13/02
Filed: 2017-06-20
Abstract: L'invention concerne un procédé de raccordement de deux éléments unitaires (2, 4) d'une conduite sous-marine de transport de fluides soumise à la fatigue, comprenant le soudage des deux éléments unitaires de conduite métalliques ou bi-métalliques mis bout à bout au niveau de leurs extrémités libres respectives (2a, 4a) en réalisant trois cordons de soudure distincts (6, 8, 10) avec un dernier cordon de soudure (8) déposé entre deux premiers cordons de soudure latéraux (6, 10), directement suivi par un sablage contrôlé des cordons de soudure pour apporter des contraintes de compression au niveau de ces derniers.